Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.230
+0.020 (1.65%)
Mar 17, 2025, 3:39 PM HKT
-6.82%
Market Cap 1.82B
Revenue (ttm) 1.16B
Net Income (ttm) 605.05M
Shares Out 1.50B
EPS (ttm) 0.40
PE Ratio 3.00
Forward PE n/a
Dividend 0.08 (6.61%)
Ex-Dividend Date n/a
Volume 508,000
Average Volume 165,400
Open 1.210
Previous Close 1.210
Day's Range 1.210 - 1.230
52-Week Range 1.090 - 1.400
Beta 0.64
RSI 56.60
Earnings Date Mar 21, 2025

About HKG:2348

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; a... [Read more]

Sector Healthcare
Founded 1995
Employees 1,143
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2348
Full Company Profile

Financial Performance

In 2023, HKG:2348's revenue was 1.15 billion, a decrease of -9.90% compared to the previous year's 1.28 billion. Earnings were 326.00 million, a decrease of -8.95%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.